Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001334549-24-000006
Filing Date
2024-10-02
Accepted
2024-10-02 17:16:01
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1727903753.html 4  
1 FORM 4 wk-form4_1727903753.xml 4 5023
  Complete submission text file 0001334549-24-000006.txt   6783
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Issuer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 ALLEN ROAD 2ND FLOOR BASKING RIDGE NJ 07920
Business Address
Mazzo David J (Reporting) CIK: 0001334549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33650 | Film No.: 241348777